Avanos Medical (AVNS) EPS (Weighted Average and Diluted) (2016 - 2026)
Avanos Medical's EPS (Weighted Average and Diluted) history spans 12 years, with the latest figure at -$0.02 for Q4 2025.
- On a quarterly basis, EPS (Weighted Average and Diluted) rose 99.77% to -$0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.57, a 81.42% increase, with the full-year FY2025 number at -$1.57, up 81.59% from a year prior.
- EPS (Weighted Average and Diluted) hit -$0.02 in Q4 2025 for Avanos Medical, up from -$0.03 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for AVNS hit a ceiling of $0.82 in Q4 2022 and a floor of -$8.64 in Q4 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.57 across 5 years, with a median of -$0.01 in 2024.
- Biggest five-year swings in EPS (Weighted Average and Diluted): soared 1416.67% in 2021 and later crashed 1944.44% in 2025.
- Tracing AVNS's EPS (Weighted Average and Diluted) over 5 years: stood at $0.24 in 2021, then skyrocketed by 241.67% to $0.82 in 2022, then tumbled by 206.1% to -$0.87 in 2023, then crashed by 893.1% to -$8.64 in 2024, then skyrocketed by 99.77% to -$0.02 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for AVNS at -$0.02 in Q4 2025, -$0.03 in Q3 2025, and -$1.66 in Q2 2025.